Intended for healthcare professionals

Letters DSM-5: a fatal diagnosis?

Academic psychiatry, research ethics, and the drug industry

BMJ 2013; 346 doi: (Published 11 June 2013) Cite this as: BMJ 2013;346:f3655
  1. Derek A Summerfield, honorary senior lecturer1
  1. 1Institute of Psychiatry, London SE5 8BB, UK
  1. derek.summerfield{at}

In his article on DSM-5 (the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders), Gornall mentions Charles Nemeroff, a professor at Emory University.1 Nemeroff concealed huge payments made covertly to him by GlaxoSmithKline, makers of the antidepressant paroxetine, while lead investigator on a National Institutes of Health (NIH) study of that very drug.2 Nemeroff was …

View Full Text

Log in

Log in through your institution


* For online subscription